It is worth noting that HDAC inhibitors are known potential anti-cancer drugs, among which there are inhibitors with a high affinity for zinc ions located in active deacetylase centres (e.g., hydroxamic acid and compounds having a benzamide group [200,201]). The gene discussed is HDAC9; the disease is cancer.